Salinocaine
SALINOCAINE OINTMENT
Approved
Approval ID
49d9f83d-3055-f80e-e58a-b6fca192ac8d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 26, 2023
Manufacturers
FDA
Medical Products Laboratories, Inc.
DUNS: 002290302
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
salicylic acid and benzocaine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10733-415
Product Classification
G
Generic Name
salicylic acid and benzocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 26, 2023
FDA Product Classification
INGREDIENTS (5)
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SALICYLIC ACIDActive
Quantity: 550 mg in 1 g
Code: O414PZ4LPZ
Classification: ACTIB
BENZOCAINEActive
Quantity: 20 mg in 1 g
Code: U3RSY48JW5
Classification: ACTIB